CTRI/2012/06/002743
Recruiting
N/A
A prospective, multi-centre, observational study to establish database toevaluate the disease progression in adults with chronic kidney disease - CKDOD
Fresenius Kabi Asia Pacific Ltd0 sites2,500 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Chronic Kidney Disease
- Sponsor
- Fresenius Kabi Asia Pacific Ltd
- Enrollment
- 2500
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Male and female patients with age \>\= 18 years and regularly attending a given site
- •2\.Patients with CKD (glomerular filtration rate (GFR) \< 90 ml/min per 1\.73 m2\) stages 2 and below (stage 2 to 5\)
- •3\.Patients with life expectancy of at least 6 months
- •4\.Patients who are willing and able to adhere to the protocol requirements
Exclusion Criteria
- •1\.Patients who have undergone kidney transplant
- •2\.Patients who have a sustained sitting systolic blood pressure (BP) more than 160 mmHg or sustained sitting diastolic BP more than 110 mmHg
- •3\.Patients with an independently co\-existing life\-threatening disease, such as cancer
- •4\.Patients who have undergone previous carotid artery surgery and/or a carotid artery stenosis greater than 75% at baseline.
- •5\.Patients with history of co\-morbidities that in the investigatorâ??s opinion would interfere with the study participation and impact life expectancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
An observational, multicentre, prospective study to see concordance of detecting EGFR mutation by circulating tumour free DNA versus tissues biopsy in Non small cell lung cancerHealth Condition 1: C342- Malignant neoplasm of middle lobe,bronchus or lungHealth Condition 2: null- Non-small cell lung cancerCTRI/2018/08/015290AstraZeneca Pharma India Ltd245
Completed
Phase 4
This is an observational study in patients to Profile Chronic Cholestatic Liver Diseases who are prescribed Udiliv for their treatmentHealth Condition 1: null- Chronic Cholestasis Liver DiseaseCTRI/2014/05/004615Abbott India Limited250
Completed
Phase 4
A prospective, observational, multi-centre study investigating alterations of gut microbiome with its subsequent interaction on the brain-immune-intestine axis in patients with active relapsing remitting Multiple Sclerosis who start with oral treatment.multiple sclerosis10029305NL-OMON54765Sint Elisabeth Ziekenhuis72
Completed
N/A
An observational multicenter study comparing Tenecteplase assisted Percutaneous Coronary Intervention (PCI) versus primary PCI in Indian patients with ST elevation Myocardial InfarctioHealth Condition 1: null- Patients with acute STEMI who are to be treated with primary PCI/pharmacoinvasive therapy within 12 hours of symptoms onset will be included.CTRI/2011/08/001950STEMI India Charitable Trust200
Completed
N/A
A multicenter, prospective, observational study evaluation the learning effect of an e-learning system-based teaching method on biliary cannulation for native papilla in ERCPJPRN-UMIN000044223Iwata city hospital12